Clinical Trials Directory

Trials / Completed

CompletedNCT04301752

Cognitive Impairment and Neuropsychiatric Manifestations of Neurobrucellosis

Status
Completed
Phase
Study type
Observational
Enrollment
82 (actual)
Sponsor
Mansoura University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Brucellosis is a common zoonotic infection in many parts of the world including the Mediterranean and Middle Eastern countries. Neurobrucellosis may develop at any stage of disease and may have widely variable manifestations, including encephalitis, meningoencephalitis, radiculitis, myelitis, peripheral and cranial neuropathies, subarachnoid hemorrhage, and psychiatric manifestations.

Detailed description

Brucellosis is a common zoonotic infection in many parts of the world including the Mediterranean and Middle Eastern countries. Neurobrucellosis may develop at any stage of disease and may have widely variable manifestations, including encephalitis, meningoencephalitis, radiculitis, myelitis, peripheral and cranial neuropathies, subarachnoid hemorrhage, and psychiatric manifestations. The aimed is to shed light to the obscure areas of diagnosis in neurobrucellosis and have detailed general and neurologic features

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMoCACognitive function was assessed by using MoCA score. Cognitive impairment was considered present when MoCA scores were \<26. Maximum score is 30.

Timeline

Start date
2019-02-01
Primary completion
2020-01-01
Completion
2020-03-01
First posted
2020-03-10
Last updated
2020-03-18

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04301752. Inclusion in this directory is not an endorsement.